Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Randomized discontinuation trials: utility and efficiency

J A Kopec1, M Abrahamowicz, J M Esdaile

  • 1Department of Epidemiology and Biostatistics, Montreal General Hospital, McGill University, Quebec, Canada.

Journal of Clinical Epidemiology
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pioglitazone and bladder cancer: improving research methods.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Risk of lung cancer in relation to various metrics of smoking history: a case-control study in Montreal.

BMC cancer·2018
Same author

A systematic review of observational studies of the association between pioglitazone use and bladder cancer.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis.

Scandinavian journal of rheumatology·2018
Same author

Relationship between physical activity and hip pain in persons with and without cam or pincer morphology: a population-based case-control study.

Osteoarthritis and cartilage·2017
Same author

The validity of a non-radiologist reader in identifying cam and pincer femoroacetabular impingement (FAI) using plain radiography.

Rheumatology international·2015
Same journal

Many multicenter randomized controlled trials do not account for center effect: a methodological review.

Journal of clinical epidemiology·2026
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
Same journal

Corrigendum to SPICE-GRADE: simultaneous processing of indirect causal evidence in complex pathways using GRADE - an exploratory case study. [Journal of Clinical Epidemiology, 194C (2026) 112219].

Journal of clinical epidemiology·2026
Same journal

Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions.

Journal of clinical epidemiology·2026
Same journal

What's the Meta Now? More Updates on the Problems with Systematic Reviews.

Journal of clinical epidemiology·2026
Same journal

A scoping review of guidance on sharing trial results with patients and the public finds inconsistent recommendations and limited methodological development.

Journal of clinical epidemiology·2026
See all related articles

The randomized discontinuation trial (RDT) offers a more efficient design for studying long-term, non-curative treatments by requiring a smaller sample size in phase II compared to classic trials. This method is particularly valuable when placebo use is ethically or practically limited.

Area of Science:

  • Clinical Trials Methodology
  • Pharmaceutical Research
  • Biostatistics

Background:

  • The randomized discontinuation trial (RDT) is a two-phase clinical trial design.
  • Phase I involves open-label treatment, while Phase II randomizes responders to treatment or placebo.
  • Exclusion of non-compliers and adverse reactors is common in Phase II.

Purpose of the Study:

  • To investigate the clinical utility and efficiency of the RDT design.
  • To compare the RDT design with classic randomized clinical trial designs.
  • To evaluate the impact of responder selection on trial efficiency.

Main Methods:

  • Review of advantages and limitations of discontinuation studies.
  • Comparison of RDT and classic randomized clinical trial designs.

Related Experiment Videos

  • Computer modeling to assess efficiency under various assumptions.

    • Main Results:

    • RDT is particularly useful for long-term, non-curative therapies with small effects, minimizing placebo use.
    • RDT is less suitable for estimating absolute treatment/toxic effects or evaluating curative treatments.
    • Selecting responders before randomization significantly enhances trial efficiency.
    • Excluding non-compliers and adverse reactors further improves efficiency.

    Conclusions:

    • RDT design can be highly efficient, requiring 20-50% of the sample size for Phase II compared to classic trials.
    • The RDT design is a valuable tool for specific therapeutic research scenarios.
    • Careful consideration of study objectives and patient selection is crucial for optimal RDT application.